Lizhu Lin

12PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMicrobial ecologyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 23, 2023
Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue.

Yingchao Wu, Shuyao Zhou, Dajin Pi

|Sep 01, 2022
<i>Yifei sanjie</i> Pills Alleviate Chemotherapy-Related Fatigue by Reducing Skeletal Muscle Injury and Inhibiting Tumor Growth in Lung Cancer Mice.

Yingchao Wu, Dajin Pi, Yiliu Chen

|Jul 30, 2021
Network Pharmacology/Metabolomics-Based Validation of AMPK and PI3K/AKT Signaling Pathway as a Central Role of Shengqi Fuzheng Injection Regulation of Mitochondrial Dysfunction in Cancer-Related Fatigue.

Wei Guo, Shan Liu, Xinting Zheng

|Jul 10, 2020
A refractory case of CDK4-amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report.

Jietao Lin, Ling Yu, Yuanfeng Fu

|Jun 18, 2020
Primary Resistance to Brigatinib in a Patient with Lung Adenocarcinoma Harboring <i>ALK</i> G1202R Mutation and <i>LIPI-NTRK1</i> Rearrangement.

Zhiwei Xiao, Xuewu Huang, Biyuan Xie

|Jun 02, 2020
Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells.

Zhuo-Xun Wu, Yuqi Yang, Guangsuo Wang

Pageof 2

Frequent Collaborators

2 joint publications

Yingchao Wu

2 joint publications

Mingzi Ouyang

1 joint publications

Wei Liu

1 joint publications

Hua-Feng Pan